Repligen Corporation

BOVESPA:R2GE34 Stock Report

Market Cap: R$44.9b

Repligen Future Growth

Future criteria checks 4/6

Repligen is forecast to grow earnings and revenue by 51.4% and 12.9% per annum respectively. EPS is expected to grow by 51.1% per annum. Return on equity is forecast to be 4.9% in 3 years.

Key information

51.4%

Earnings growth rate

51.1%

EPS growth rate

Life Sciences earnings growth0%
Revenue growth rate12.9%
Future return on equity4.9%
Analyst coverage

Good

Last updated20 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:R2GE34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268027015718710
12/31/20256974710216215
12/31/2024634169415616
9/30/2024634-8131165N/A
6/30/20246209119155N/A
3/31/202462024110147N/A
12/31/20236323675114N/A
9/30/202365310197147N/A
6/30/202371212451149N/A
3/31/202376115446160N/A
12/31/202280218639172N/A
9/30/202280116615160N/A
6/30/202277915941141N/A
3/31/202273414642133N/A
12/31/202167112848119N/A
9/30/20215931193584N/A
6/30/20215091004083N/A
3/31/2021433803262N/A
12/31/2020366603663N/A
9/30/2020327444465N/A
6/30/2020302314266N/A
3/31/2020286234367N/A
12/31/2019270214467N/A
9/30/2019253233455N/A
6/30/2019233273453N/A
3/31/2019210212541N/A
12/31/2018194171933N/A
9/30/2018184233242N/A
6/30/201817123N/A21N/A
3/31/201815529N/A18N/A
12/31/201714128N/A17N/A
9/30/201712521N/A4N/A
6/30/201711318N/A5N/A
3/31/201711013N/A12N/A
12/31/201610512N/A8N/A
9/30/20161007N/A9N/A
6/30/2016968N/A17N/A
3/31/2016888N/A14N/A
12/31/2015849N/A15N/A
9/30/2015789N/A13N/A
6/30/2015748N/A13N/A
3/31/2015687N/A8N/A
12/31/2014648N/A18N/A
9/30/20146312N/A24N/A
6/30/20146616N/A24N/A
3/31/20146818N/A30N/A
12/31/20136816N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: R2GE34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.4%).

Earnings vs Market: R2GE34 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: R2GE34 is expected to become profitable in the next 3 years.

Revenue vs Market: R2GE34's revenue (12.9% per year) is forecast to grow faster than the BR market (7.4% per year).

High Growth Revenue: R2GE34's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: R2GE34's Return on Equity is forecast to be low in 3 years time (4.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y